Bill Rhodes

Bill Rhodes is an accomplished professional with extensive experience in the life sciences and healthcare sectors. Currently serving as Chairman of the Board for OpGen, Inc. and GEN inCode Predictive Genetics, Rhodes also holds board positions at Nodexus Inc. and OncoDNA, focusing on innovative solutions for precision medicine and genetic insights. In addition to their leadership roles, Rhodes is Managing Partner at Third Day Advisors LLC, providing strategic advisory services, and an Operating Partner at Altaris Capital Partners, where Bill aids in acquiring and developing life sciences companies. Additionally, Rhodes contributes to education as a Senior Executive in Residence at Cornell University and a Clinical Instructor at Weill Cornell Medicine, mentoring entrepreneurs and enhancing healthcare strategies. Rhodes holds a BS in Entomology from Cornell University and an MS in International Business from Seton Hall University.